Automation And Biopharma Outsourcing Will Drive Market Expansion

Shared on01 May 25
Fair value Decreased 9.09%

Shared on24 Apr 25
Fair value Decreased 0.63%

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.64%

AnalystConsensusTarget has increased future PE multiple from 90.4x to 123.7x and increased shares outstanding growth rate from 0.0% to 0.1%.